Frédérique Menzaghi
2016
In 2016, Frédérique Menzaghi earned a total compensation of $780.5K as Chief Scientific Officer and Senior Vice President, R&D at Cara Therapeutics, a 10% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $168,682 |
|---|---|
| Option Awards | $246,878 |
| Salary | $357,000 |
| Other | $7,950 |
| Total | $780,510 |
Menzaghi received $357K in salary, accounting for 46% of the total pay in 2016.
Menzaghi also received $168.7K in non-equity incentive plan, $246.9K in option awards and $8K in other compensation.
Rankings
In 2016, Frédérique Menzaghi's compensation ranked 9,393rd out of 14,075 executives tracked by ExecPay. In other words, Menzaghi earned more than 33.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,393 out of 14,075 | 33rd |
Division Manufacturing | 3,634 out of 5,489 | 34th |
Major group Chemicals And Allied Products | 1,261 out of 1,895 | 34th |
Industry group Drugs | 1,002 out of 1,538 | 35th |
Industry Pharmaceutical Preparations | 790 out of 1,176 | 33rd |
Source: SEC filing on April 24, 2019.
Menzaghi's colleagues
We found two more compensation records of executives who worked with Frédérique Menzaghi at Cara Therapeutics in 2016.
News
Cara Therapeutics CEO Derek Chalmers' 2021 pay jumps 250% to $10M
April 22, 2022
Cara Therapeutics CEO Derek Chalmers' 2020 pay slips 15% to $2.9M
April 23, 2021
Cara Therapeutics CEO Derek Chalmers' 2019 pay jumps 23% to $3.4M
April 22, 2020
Cara Therapeutics Chief Medical Officer Joana Goncalves receives $3.7M in 2018
April 24, 2019